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I~  Cross-sectional- and long-term-ultrasound bone density 
assessment in pediatric and adult patients with Cystic Fibrosis 
J. Mainz 1 , H.J. Mentzel 2, B. Wiedemann 3, A. Malich 2, D. Sauner 2, D. Ibrahim 1 , 
W.A. Kaiser 2, E Zintl 1 . 1 CF Centre, 2Radiology, Friedrich-Schiller-University 
.lena; 3 Med. Injbrmatics and Biometrics', University Dresden, Germany 
Bone density assessment regularly implies radiation and often lacks of regional 
normative values, especially in childhood. 
Aim of the present study was to assess ultrasonic bone density (BD) at the calcaneal 
bone from pediatric and adult patients with CF in a cross-sectional- nd long term 
setting. The pediatric results were compared toregional reference data obtained with 
the identical system from 3299 healthy controls aged 6 to 18yrs. BD parameters 
were assessed with the SAHARA TM system in 54 CF patients in a cross sectional 
setting and in 35 CF patients for a long term of up to 7 years. 
Cross sectional analysis revealed an increased rate of reduced BUA and SOS-values 
in CF patients [BUA ~< 1 standard eviation score (SDS): 13/54 (24.1%) resp. 
>1SDS: 7 (13.0%); SOS~< 1SDS 16/54 (29.6%) resp. >1SDS: 10 (18.5%)]. The 
differences were more pronounced in children than in adults. Long term observation 
revealed a decrease of BUA and SOS Z-scores in the 21 patients followed for 
at least 48 months. Most distinctive reduction was found in SOS Z-scores from 
children controlled after 12 24 months (n 7, mean 0.47, p 0.003) and in adults 
controlled after 24 36 months (n 20, mean 0.39, p 0.032). 
Altogether we found a relevant proportion of reduced BUA and SOS values in 
CF-patients. The higher proportion of children with reduced values could coincide 
with the presence of relevant local reference data, whereas we did not propose about 
similar references in adults. 
Although variance of ultrasonic BD-measurement is higher than in the standards 
DXA or Q-CT, which imply radiation, the method may be a tool for frequent 
follow-ups in CE 
7. Metabolic complications of CF 
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Bone loss is a recognised complication of CE Previously we performed DEXA 
scans on patients we identified as being at increased risk of developing bone 
disease:(steroids, low Vit D levels, low BMI, diabetes, >40 years, on transplant list). 
Results confirmed a high prevalence of bone disease in this group. We performed 
DEXA scans on the remaining clinic population to determine overall prevalence in
our clinic. 
Aims: To investigate the prevalence of bone disease in all patients in our CF 
centre. To review the current reatment of bone disease in our clinic population. To 
investigate relevance of repeating DEXA scans 2 yearly. To update guidelines for 
the detection and management of bone disease within our CF centre. 
Methods: DEXA scans were performed on all patients in our clinic. Patients who 
had previously been scanned had a repeat scan 2 years after their initial scan. 
Results: DEXA scans have been performed on 98 patients. 23 have osteoporosis, 
47 have osteopenia nd 12 have normal scans. 16 patients were <20 years old 
and could not be classified under the WHO definition. 27 repeat scans have been 
performed with 4 results showing different diagnosis from original scans. 3 results 
changed from osteopenia to osteoporosis, 1 result showed change from osteopenia 
to normal. Further analysis of data is ongoing to look at risk of low vitamin D 
levels within clinic. 
Conclusions: Bone loss is high in our CF population, including in some patients 
identified as low risk. Results in those <20 years are difficult to interpret as bone 
is still being laid down. This raises questions as to when treatment should be 
instigated in this group. Changes in bone density can be detected within a 2-year 
period. Guidelines require to be updated to include treatment for our <20 years 
population. 
I •  Frequency and risk factors of osteopenia/osteoporosis in 
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It was shown in different studies that reduced bone mineral density (BMD) is often 
complication i CF and can significantly reduce life quality of these patients. 
Aim: to determine frequency of osteopenia nd osteoporosis n CF children, to 
compare frequency of reduced BMD in CF children and healthy Russian population 
the same age and to identify risk factors. 
Methods: 44 CF children (24M/20R 5.4 17.9yrs, mean FEVI% 67.87%±23.14) 
were studied. 14 (32%) children have "moderate" and 30 (68%) "severe" phenotype. 
5 (11%) children used inhaled steroids, 7 (16%) oral steroids (0.5mg/kg more 
than 1 year). Bone mineral content(BMC) and BMD are measured using DEXA 
scans of the lumbar spine (L2-L4). Anthropometric parameters, clinical markers 
of disease severity, pulmonary function tests (FVC, FEVI%), serum calcium and 
phosphor, alkaline phosphatase were assessed and related to bone mineral density. 
Results: osteoporosis was found in 43% (meanZ-score-3.5, S.D. 0.97), osteopenia 
(mean Z-score-l.52, S.D. 0.35) in 34% cases. However the complaints on a pain 
in bones and back were only at 7 (16%) patients, nobody had an atraumatic 
fracture. While at healthy Russian children low BMD is revealed at 10 30%. 
There was no correlation between BMD and gender, age, inhaled steroids. We 
have observed correlation between BMD and weight/height (r 0.38,p <0.05), 
FEVI% (r 0.39,p<0.02), FVC (r 0.39, p<0.02), long term oral steroids 
(r 0.41,p < 0.01). 
Conelnslon: reduced bone mineral density is often complication i  CF children. 
The frequency reduced BMD at children with CF in 2 times is higher than at 
healthy children. The condition of lungs functions is one of the important factors 
determining BMD. 
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The aim of the study was to determine the prevalence and identify determinants 
of reduced bone mineral density (BMD) in children and adolescents with cystic 
fibrosis (CF). 
Children (30) with CF (mean±SD age 11.5±4.5 yrs); forced expiratory volume in 
one second (FEV1) 87.8±24.5% of the predicted value was studied. 
The method of quantitative ultrasound (QUS) was used for determination of 
the bone status. Speed of sound (SOS), transmission i dex (TI) and osteosono- 
assesment (OSI) were measured by calcaneal ultrasound.FEV1 (% pred); CF 
genotype; malnutrition, history of growth, development or weight gain delay and 
corticosteroids u e were analysed. 
The mean values of Z score in CF patients were for SOS ( 0.2±1.4); for TI 
(0.6±1.1) and for OSI ( 0.5± 1.2). We found 10 patients (33%) with reduced 
bone density. All of them were homozygous or heterozygous for the AF508 
mutation. Malnutrition, lower 25-hydroxyvitamin D level and lower FEV1 (% pred) 
associated with lower BMD. 
In conclusion, reduced BMD in CF patients is associated with a number of factors, 
including AF508 genotype, male sex, greater lung disease severity and malnutrition 
